Navigation Links
angelMD Completes Investment in Bleeding Detection Medical Device Company
Date:6/15/2017

angelMD announced the closure of a new syndicate investment in Saranas, a promising new medical device startup. Dan Parsley, angelMD’s SVP of Corporate Development, served as the syndicate leader for this first investment in Saranas by angelMD members, and this angelMD syndicate is part of Saranas’ recently announced $4 million Series B financing round.

Saranas is working to create a way to quickly and accurately diagnose complications in vascular access procedures, while lowering patient and provider costs. Every year, twenty million American patients undergo these procedures to provide longer term access for intravenous (IV) medical treatments, and as many as a million of these patients experience life-threatening complications as a result of an inability to quickly account for problems like internal bleeding. These issues cost patients and providers a collective $8.4B dollars each year.

“With the growth of value-based insurance reimbursements combined with the increasing popularity of intravenous heart procedures, patients and doctors are demanding better procedural outcomes,” said Parsley. “This innovative real-time bleeding detection device by Dr. Razavi is designed to be integrated directly into common catheter sheaths, and I’m confident many existing cardiac medical device companies will see the immediate value of this technology.”

Saranas is angelMD’s first investment of technology originating from the prestigious Texas Heart Institute at the Texas Medical Center.

Saranas CEO Zaffer Syed said, “We are thrilled to be adding angelMD to our investor base. With access to physician investors, angelMD brings a strong track record of adding real value to its portfolio companies. This Series B financing reflects a deep commitment to Saranas’ innovative approach for enhancing patient outcomes during vascular access procedures.”

“Saranas has the management team and an experienced board that will be able to see this innovative technology through FDA clearance, and we are excited to help this company grow and become an industry leader,” concluded Parsley.

About angelMD
angelMD is an investment platform and marketplace connecting innovative medical startups, physicians, investors and industry partners. Leading physicians from all over the US have joined the angelMD Scientific Advisory Board and Leaders Club to help source, evaluate and advise companies in biotechnology, medical device and healthcare technology. For more information, visit http://www.angelmd.co.

About Saranas
Saranas is a privately held Houston, Texas-based medical device company focused on improving patient outcomes through early detection of internal bleeding complications. The company’s patented introducer sheath technology for vascular access procedures enables physicians to mitigate downstream consequences by addressing bleeding complications immediately, improving patient outcomes and lowering healthcare costs. For more on their pioneering technology, visit

Read the full story at http://www.prweb.com/releases/2017/06/prweb14428796.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. 3 angelMD Startups Make Livestrong Big C Semi-finals
2. BGI-Shenzhen Completes Acquisition of Complete Genomics
3. Novira Therapeutics Completes $25 Million Series A Financing
4. bioRASI Completes Acquisition of Ukrainian CRO
5. Centene Corporation Completes Acquisition Of Specialty Pharmacy Leader AcariaHealth
6. St. Mary Completes Phase 2 of Its Emergency Department and Trauma Center Expansion
7. Leviticus Cardio Ltd. Completes a Successful Animal Trial for its Wireless Energy System for VADs
8. Oligomerix, Inc. Completes Series B Financing
9. Eurofins MWG Operon Quality Assurance Group Completes ISO Certifications for Their New Overnight Sequencing Lab
10. SureClinical Completes FDA 21 CFR Part 11 Compliance Audit of SureTrial® eTMF Cloud Edition
11. Boston Scientific Completes $1.05 Billion Senior Notes Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2020)... ... March 31, 2020 , ... Carterra® Inc., the world leader in high-throughput antibody ... they will use Carterra’s proprietary LSA™ platform to screen hundreds of antibodies in just ... as this summer. , La Jolla Institute for Immunology (LJI) has been ...
(Date:3/19/2020)... ... March 18, 2020 , ... Family counsellors, marriage/couples therapists, ... rapid insight into their perceptions of events. Imagine if a couple’s counsellor could ... they could measure the level of engagement of each individual in the therapeutic ...
(Date:3/10/2020)... ... March 10, 2020 , ... Lifecycle Biotechnologies announced ... in Cleburne, Texas to be used as a biopharmaceutical and biotechnology production and development ... sales offices as well as its production and development hub. The company expects to ...
(Date:3/2/2020)... FREDERICK, Md. (PRWEB) , ... March 02, 2020 , ... ... Top Patent Firms 2019 list in the field of Biotechnology and Organics. , According ... counsel on a total of 259 patents issued in technology center 1600 during 2019. ...
Breaking Biology Technology:
(Date:3/2/2020)... ... March 02, 2020 , ... Philadelphia IP law firm ... Ph.D., J.D. has joined the firm as a Partner, and Stephany G. Small, Ph.D., ... experienced patent attorney and will be a partner in the firm’s biotechnology and life ...
(Date:3/2/2020)... ... , ... Rigaku Corporation is pleased to announce ... Spectroscopy ( Pittcon 2020 ), being held March 1 - 5, at McCormick ... on laboratory science, attracting attendees from industry, academia and government from over 90 ...
(Date:2/28/2020)... ... February 26, 2020 , ... ... Rebound PRF® devices are now available to veterinary practices through Covetrus. Enso ... that will provide the most affordable, easiest to use, multi-species validated, platelet-rich ...
Breaking Biology News(10 mins):